Navigation Links
CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
Date:7/29/2008

estones ahead of schedule including initiation of the Phase II breast cancer trial and accelerated enrollment of patients into the Phase II melanoma trial," commented Dr. Tim Shannon, President and Chief Executive Officer of CuraGen. "Over the remainder of 2008, we look forward to completing enrollment in the melanoma study and subsequently presenting updated results during the fourth quarter of this year."

About CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a dedicated clinical-stage biopharmaceutical company developing diverse approaches for the treatment of cancer. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.

Forward-Looking Statements

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to the Company's revenue, expenses, depreciation, amortization, asset impairment charges, losses, income, and future cash and investment positions, including for the second half of 2008 and fiscal year 2008, the timing and expected results of our clinical programs, and the development and marketability of planned drugs, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
10. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... DIEGO , Dec. 23, 2014 ResMed (NYSE: ... significant patent infringement action against Chinese medical device manufacturer BMC ... (ITC) ruled today that BMC,s masks listed below infringe ResMed,s ... or selling these masks in the United States ... iVolve N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... decision support to healthcare providers for behavioral health ... has secured $30 million in equity financing from ... C. Drosos , President and Chief Executive Officer. ... adoption and development of Assurex Health,s GeneSight ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... 5, 2011 Reportlinker.com announces that ... available in its catalogue: ... Assessments of Leading Suppliers ... This report provides industry executives with ...
... 5, 2011 Reportlinker.com announces that a new ... China In Vitro Diagnostics ... http://www.reportlinker.com/p0240263/China-In-Vitro-Diagnostics-Market-Outlook-to-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic China In Vitro ... Summary GlobalData,s new report, "China ...
Cached Medicine Technology:Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 2Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 3Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 4Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 5Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 6Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers 7China In Vitro Diagnostics Market Outlook to 2016 2China In Vitro Diagnostics Market Outlook to 2016 3China In Vitro Diagnostics Market Outlook to 2016 4China In Vitro Diagnostics Market Outlook to 2016 5China In Vitro Diagnostics Market Outlook to 2016 6China In Vitro Diagnostics Market Outlook to 2016 7China In Vitro Diagnostics Market Outlook to 2016 8China In Vitro Diagnostics Market Outlook to 2016 9China In Vitro Diagnostics Market Outlook to 2016 10China In Vitro Diagnostics Market Outlook to 2016 11China In Vitro Diagnostics Market Outlook to 2016 12China In Vitro Diagnostics Market Outlook to 2016 13China In Vitro Diagnostics Market Outlook to 2016 14China In Vitro Diagnostics Market Outlook to 2016 15China In Vitro Diagnostics Market Outlook to 2016 16
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter TUESDAY, ... have abstained from sex for one year will be allowed to ... that would reverse a 31-year ban on donations from men who ... announced Tuesday its intention to release a new draft guidance in ... from gay men. The FDA is changing its policy based ...
(Date:12/24/2014)... (HealthDay News) -- Researchers say they have used human ... eggs and sperm. While this had already been ... time that these types of cells -- called primordial ... stem cells, according to the team at the University ... germ cells is one of the earliest events during ...
(Date:12/24/2014)... December 24, 2014 For chic ladies, new ... As a part of their Holiday Wish List, Angeldress.co.uk ... as perfect ways to accent ladies’ holiday wardrobe by launching ... should be all over the discount of 80% off, like ... ready to ship. The company’s chic wedding dresses are among ...
(Date:12/24/2014)... There’s a lot going on with The ... now in control of the Senate as well as the ... Act. A lawsuit has been brought against President Obama by ... the ACA have resulted in changes to the law without ... will take place to weigh the validity of subsidies provided ...
(Date:12/24/2014)... December 24, 2014 Attorneys handling talcum ... an update to their website, the Talcum Powder ... between talcum powder class action lawsuits and ovarian cancer ... and ovarian cancer updates at their website, which serves ... for ovarian cancer claims are not the same as ...
Breaking Medicine News(10 mins):Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 4
... at Galveston researchers have achieved promising results with a ... common cause of infant hospitalization in the United States. ... therapy for RSV, the scientists tested two types of ... that RSV uses to replicate, or copy itself, within ...
... in New Public Service Advertisement ... ... and Brittany Lietz wanted was a dark tan. They thought it made,them ... they,would be battling melanoma, the deadliest form of skin cancer. Now Meghan,24, ...
... Needed to Prepare,for Future Disasters Especially on the Eve ... American Red Cross,today announced that it has met the ... its Disaster Relief Fund are still,needed to ensure it ... of hurricane season starting in less than a month., ...
... With spring in the air, most of,us ... that warm weather,brings -- flip flops, shorts, sunglasses, ... in sunscreen protection have become more,plentiful than ever, ... from ultraviolet (UV) light. Fortunately,dermatologists can help you ...
... License for Pulse!! Virtual Learning Platform for ... Clinical Skills and Decision Making Training, ... of,game-based technology solutions for training, experimentation and,decision-making analysis, has ... for the exclusive, worldwide rights to Pulse!! the,Virtual Clinical ...
... Floral Bouquet Purchased at, http://www.proflowers.com/CHF Will ... Ill., May 5 The Children,s Heart,Foundation today ... fresh flower marketplace -- just in time for ... http://www.proflowers.com/CHF and choose,from a variety of ...
Cached Medicine News:Health News:New agent strikes at respiratory syncytial virus replication 2Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 2Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 3Health News:Indoor Tanning is Not as Safe as You Think. In Fact, It's Totally Out: 4Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to Southeastern Virginia Tornadoes 2Health News:Generous Donors Allow Red Cross to Respond Swiftly and Effectively to Southeastern Virginia Tornadoes 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 2Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 3Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 4Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 5Health News:Recent Advances Make Sunscreen More Effective and Easier to Use 6Health News:Game-Based Technology to Meet Demand for Improved Medical Teaching and Training 2Health News:Game-Based Technology to Meet Demand for Improved Medical Teaching and Training 3Health News:The Children's Heart Foundation Teams Up With ProFlowers(R) to Raise Awareness and Funding for the Leading Birth Defect in America 2Health News:The Children's Heart Foundation Teams Up With ProFlowers(R) to Raise Awareness and Funding for the Leading Birth Defect in America 3
... the first intra-operative fluorescent imaging system ... the location of the coronary arteries ... coronary artery bypass procedures. ,The patented ... to view, record, replay, print, and ...
... When myocardial infarction is ... TROPT sensitive rapid assay allows ... marker troponin T from a ... qualitative result is available within ...
The Polygraf ID multi-parametric recorder works with POLYGRAM NET analysis software to create a unique interface that combines web-style navigation, graphical presentation and intuitive design to del...
... The White Sun light source offers the industry ... Kelvin color temperature at a lower price. A ... White Sun to be used with Olympus, Storz, ... light output LED and re-settable bulb timer. The ...
Medicine Products: